SEARCH

SEARCH BY CITATION

References

  • Attanasio, M., Gori, A.M., Giusti, B., Pepe, G., Comeglio, P., Brunelli, T., Prisco, D., Abbate, R., Gensini, G.F. & Neri Serneri, G.G. (1998) Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin. Thrombosis and Haemostasis, 79, 959962.
  • Baeuerle, P.A. & Baichwal, V.R. (1997) NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Advances in Immunology, 65, 111137.
  • Baldwin, A.S. Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology, 14, 649683.
  • Barnes, P.J. & Karin, M. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine, 336, 10661071.
  • Bohrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Mannel, D., Bottiger, B.W., Stern, D.M., Waldherr, R., Saeger, H.D., Ziegler, R., Bierhaus, A., Martin, E. & Nawroth, P.P. (1997) Role of NFkappaB in the mortality of sepsis. The Journal of Clinical Investigation, 100, 972985.
  • Bourin, M.C. & Lindahl, U. (1993) Glycosaminoglycans and the regulation of blood coagulation. Biochemical Journal, 289, 313330.
  • Diamant, Z., Timmers, M.C., Van der Veen, H., Page, C.P., Van der Meer, F.J. & Sterk, P.J. (1996) Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. American Journal of Respiratory and Critical Care Medicine, 153, 17901795.
  • Evans, R.C., Wong, V.S., Morris, A.I. & Rhodes, J.M. (1997) Treatment of corticosteroid-resistant ulcerative colitis with heparin – a report of 16 cases. Alimentary Pharmacology and Therapeutics, 11, 10371040.
  • Feldmann, M., Brennan, F.M., Elliott, M., Katsikis, P. & Maini, R.N. (1994) TNF alpha as a therapeutic target in rheumatoid arthritis. Circulatory Shock, 43, 179184.
  • Gaffney, A. & Gaffney, P. (1996) Rheumatoid arthritis and heparin. British Journal of Rheumatology, 35, 808809.
  • Gaffney, P.R., O'Leary, J.J., Doyle, C.T., Gaffney, A., Hogan, J., Smew, F. & Annis, P. (1991) Response to heparin in patients with ulcerative colitis. Lancet, 337, 238239.
  • Gaffney, P.R., Doyle, C.T., Gaffney, A., Hogan, J., Hayes, D.P. & Annis, P. (1995) Paradoxical response to heparin in 10 patients with ulcerative colitis. American Journal of Gastroenterology, 90, 220223.
  • Gori, A.M., Attanasio, M., Gazzini, A., Rossi, L., Lucarini, L., Miletti, S., Chini, J., Manoni, M., Abbate, R. & Gensini, G.F. (2004) Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives. Journal of Thrombosis and Haemostasis, 2, 16571662.
  • Hecht, I., Hershkoviz, R., Shivtiel, S., Lapidot, T., Cohen, I.R., Lider, O. & Cahalon, L. (2004) Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling. Journal of Leukocyte Biology, 75, 11391146.
  • Hirsh, J. & Raschke, R. (2004) Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(Suppl. 3), 188S203S.
  • Hirsh, J., Warkentin, T.E., Shaughnessy, S.G., Anand, S.S., Halperin, J.L., Raschke, R., Granger, C., Ohman, E.M. & Dalen, J.E. (2001) Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest, 119(Suppl. 1), 64S94S.
  • Hogasen, A.K. & Abrahamsen, T.G. (1995) Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production. Thrombosis Research, 80, 179184.
  • Lever, R. & Page, C.P. (2002) Novel drug development opportunities for heparin. Nature Reviews Drug Discovery, 1, 140148.
  • Lever, R., Hoult, J.R. & Page, C.P. (2000) The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro. British Journal of Pharmacology, 129, 533540.
  • Manduteanu, I., Voinea, M., Antohe, F., Dragomir, E., Capraru, M., Radulescu, L. & Simionescu, M. (2003) Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology, 477, 269276.
  • Page, C.P. (1991) One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet, 337, 717720.
  • Seeds, E.A. & Page, C.P. (2001) Heparin inhibits allergen-induced eosinophil infiltration into guinea-pig lung via a mechanism unrelated to its anticoagulant activity. Pulmonary Pharmacology and Therapeutics, 14, 111119.
  • Smailbegovic, A., Lever, R. & Page, C.P. (2001) The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells. British Journal of Pharmacology, 134, 827836.
  • Teixeira, M.M. & Hellewell, P.G. (1993) Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin. British Journal of Pharmacology, 110, 14961500.
  • Thourani, V.H., Brar, S.S., Kennedy, T.P., Thornton, L.R., Watts, J.A., Ronson, R.S., Zhao, Z.Q., Sturrock, A.L., Hoidal, J.R. & Vinten-Johansen, J. (2000) Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury. American Journal of Physiology, Heart and Circulatory Physiology, 278, 20842093.
  • Vancheri, C., Mastruzzo, C., Armato, F., Tomaselli, V., Magri, S., Pistorio, M.P., LaMicela, M., D'Amico, L. & Crimi, N. (2001) Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology, 108, 703708.
  • White, B., Schmidt, M., Murphy, C., Livingstone, W., O'Toole, D., Lawler, M., O'Neill, L., Kelleher, D., Schwarz, H.P. & Smith, O.P. (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. British Journal of Haematology, 110, 130134.
  • Yanaka, K. & Nose, T. (1996) Heparin ameliorates brain injury by inhibiting leukocyte accumulation. Stroke, 27, 21462147.
  • Yao, J., Mackman, N., Edgington, T.S. & Fan, S.T. (1997) Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. Journal of Biological Chemistry, 272, 1779517801.